{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T05:15:11Z","timestamp":1790054111360,"version":"4.0.1"},"reference-count":42,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2016,6,1]],"date-time":"2016-06-01T00:00:00Z","timestamp":1464739200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,4,17]],"date-time":"2018-04-17T00:00:00Z","timestamp":1523923200000},"content-version":"vor","delay-in-days":685,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Genomics"],"published-print":{"date-parts":[[2016,6]]},"DOI":"10.1016\/j.ygeno.2016.04.005","type":"journal-article","created":{"date-parts":[[2016,5,1]],"date-time":"2016-05-01T15:45:31Z","timestamp":1462117531000},"page":"223-230","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":46,"title":["Integrated analysis of multidimensional omics data on cutaneous melanoma prognosis"],"prefix":"10.1016","volume":"107","author":[{"given":"Yu","family":"Jiang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xingjie","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Krauthammer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bonnie E. Gould","family":"Rothberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuangge","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"36","key":"10.1016\/j.ygeno.2016.04.005_bb0005","doi-asserted-by":"crossref","first-page":"6199","DOI":"10.1200\/JCO.2009.23.4799","article-title":"Final version of 2009 AJCC melanoma staging and classification","volume":"27","author":"Balch","year":"2009","journal-title":"J. Clin. Oncol. Off. J. Am. Soc. Clin. Oncol."},{"issue":"1","key":"10.1016\/j.ygeno.2016.04.005_bb0010","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.chemolab.2007.09.009","article-title":"Deviance residuals based PLS regression for censored data in high dimensional setting","volume":"91","author":"Bastien","year":"2008","journal-title":"Chemom. Intell. Lab. Syst."},{"issue":"3","key":"10.1016\/j.ygeno.2016.04.005_bb0015","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.bcp.2013.11.013","article-title":"Emerging insights into resistance to BRAF inhibitors in melanoma","volume":"87","author":"Bucheit","year":"2014","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ygeno.2016.04.005_bb0020","series-title":"Melanoma Development: Molecular Biology, Genetics and Clinical Application","author":"Bosserhoff","year":"2011"},{"issue":"7418","key":"10.1016\/j.ygeno.2016.04.005_bb0025","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1038\/nature11412","article-title":"N. Comprehensive molecular portraits of human breast tumors","volume":"490","author":"Cancer Genome Atlas","year":"2012","journal-title":"Nature"},{"issue":"7492","key":"10.1016\/j.ygeno.2016.04.005_bb0030","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1038\/nature12965","article-title":"N. Comprehensive molecular characterization of urothelial bladder carcinoma","volume":"507","author":"Cancer Genome Atlas Research","year":"2014","journal-title":"Nature"},{"issue":"7511","key":"10.1016\/j.ygeno.2016.04.005_bb0035","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1038\/nature13385","article-title":"N. Comprehensive molecular profiling of lung adenocarcinoma","volume":"511","author":"Cancer Genome Atlas Research","year":"2014","journal-title":"Nature"},{"issue":"7","key":"10.1016\/j.ygeno.2016.04.005_bb0040","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1016\/j.cell.2015.05.044","article-title":"N. Genomic classification of cutaneous melanoma","volume":"161","author":"Cancer Genome Atlas Research","year":"2015","journal-title":"Cell"},{"issue":"8","key":"10.1016\/j.ygeno.2016.04.005_bb0045","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1007\/s00251-008-0303-5","article-title":"Analysis of HLA class I expression in progressing and regressing metastatic melanoma lesions after immunotherapy","volume":"60","author":"Carretero","year":"2008","journal-title":"Immunogenetics"},{"issue":"6","key":"10.1016\/j.ygeno.2016.04.005_bb0050","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1373\/clinchem.2013.213611","article-title":"Genome-wide characterization of circulating tumor cells identifies novel prognostic genomic alterations in systemic melanoma metastasis","volume":"60","author":"Chiu","year":"2014","journal-title":"Clin. Chem."},{"key":"10.1016\/j.ygeno.2016.04.005_bb0055","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/j.1467-9868.2009.00723.x","article-title":"Sparse partial least squares regression for simultaneous dimension reduction and variable selection","volume":"72","author":"Chun","year":"2010","journal-title":"J. R. Stat. Soc. Ser. B"},{"issue":"2","key":"10.1016\/j.ygeno.2016.04.005_bb0060","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1111\/j.1755-148X.2011.00828.x","article-title":"DNA-methylation profiling distinguishes malignant melanomas from benign nevi","volume":"24","author":"Conway","year":"2011","journal-title":"Pigment Cell Melanoma Res."},{"issue":"2","key":"10.1016\/j.ygeno.2016.04.005_bb0065","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1097\/PPO.0b013e31824d448c","article-title":"The role of the PI3K-AKT pathway in melanoma","volume":"18","author":"Davies","year":"2012","journal-title":"Cancer J."},{"issue":"1","key":"10.1016\/j.ygeno.2016.04.005_bb0070","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.soc.2010.09.007","article-title":"Staging and prognosis of cutaneous melanoma","volume":"20","author":"Dickson","year":"2011","journal-title":"Surg. Oncol. Clin. N. Am."},{"issue":"11","key":"10.1016\/j.ygeno.2016.04.005_bb0075","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1089\/gtmb.2013.0226","article-title":"Screening biomarkers of prostate cancer by integrating microRNA and mRNA microarrays","volume":"17","author":"Feng","year":"2013","journal-title":"Genet. Test. Mol. Biomarkers"},{"issue":"2","key":"10.1016\/j.ygeno.2016.04.005_bb0080","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1056\/NEJMoa1203421","article-title":"Improved survival with MEK inhibition in BRAF-mutated melanoma","volume":"367","author":"Flaherty","year":"2012","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.ygeno.2016.04.005_bb0085","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1158\/1078-0432.CCR-13-3316","article-title":"Development of a prognostic genetic signature to predict the metastatic risk associated with cutaneous melanoma","volume":"21","author":"Gerami","year":"2015","journal-title":"Clin. Cancer Res."},{"issue":"10","key":"10.1016\/j.ygeno.2016.04.005_bb0090","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1038\/nrm1490","article-title":"Integrin signalling during tumour progression","volume":"5","author":"Guo","year":"2004","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"7","key":"10.1016\/j.ygeno.2016.04.005_bb0095","doi-asserted-by":"crossref","first-page":"1","DOI":"10.18637\/jss.v045.i07","article-title":"Amelia II: a program for missing data","volume":"45","author":"Honaker","year":"2011","journal-title":"J. Stat. Softw."},{"issue":"5","key":"10.1016\/j.ygeno.2016.04.005_bb0100","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1016\/j.bcp.2010.04.029","article-title":"Targeting the MAPK pathway in melanoma: why some approaches succeed and other fail","volume":"80","author":"Inamdar","year":"2010","journal-title":"Biochem. Pharmacol."},{"issue":"4","key":"10.1016\/j.ygeno.2016.04.005_bb0105","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1002\/ijc.29047","article-title":"Determination of prognosis in metastatic melanoma through integration of clinico-pathologic, mutation, mRNA, microRNA, and protein information","volume":"136","author":"Jayawardana","year":"2015","journal-title":"Int. J. Cancer"},{"issue":"9","key":"10.1016\/j.ygeno.2016.04.005_bb0115","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1038\/ng.2359","article-title":"Exome sequencing identifies recurrent somatic RAC1 mutations in melanoma","volume":"44","author":"Krauthammer","year":"2012","journal-title":"Nat. Genet."},{"issue":"11","key":"10.1016\/j.ygeno.2016.04.005_bb0120","doi-asserted-by":"crossref","first-page":"1792","DOI":"10.1038\/cdd.2014.121","article-title":"E3 ubiquitin ligase TRIM32 negatively regulates tumor suppressor p53 to promote tumorigenesis","volume":"21","author":"Liu","year":"2014","journal-title":"Cell Death Differ."},{"issue":"5","key":"10.1016\/j.ygeno.2016.04.005_bb0125","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1016\/j.suc.2014.07.003","article-title":"Surviving cutaneous melanoma: a clinical review of follow-up practices, surveillance, and management of recurrence","volume":"94","author":"Mrazek","year":"2014","journal-title":"Surg. Clin. North Am."},{"issue":"4","key":"10.1016\/j.ygeno.2016.04.005_bb0130","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1097\/00008390-200108000-00010","article-title":"Serum imbalance of cytokines in melanoma patients","volume":"11","author":"Moretti","year":"2001","journal-title":"Melanoma Res."},{"issue":"3","key":"10.1016\/j.ygeno.2016.04.005_bb0135","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.csda.2003.08.001","article-title":"On partial least squares dimension reduction for microarray-based classification: a simulation study","volume":"46","author":"Nguyen","year":"2004","journal-title":"Comput. Stat. Data Anal."},{"issue":"5","key":"10.1016\/j.ygeno.2016.04.005_bb0140","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1158\/1078-0432.CCR-11-2271","article-title":"Combination of a novel gene expression signature with a clinical nomogram improves the prediction of survival in high-risk bladder cancer","volume":"18","author":"Riester","year":"2012","journal-title":"Clin. Cancer Res."},{"issue":"2","key":"10.1016\/j.ygeno.2016.04.005_bb0145","doi-asserted-by":"crossref","first-page":"516","DOI":"10.3892\/ijo.2014.2481","article-title":"Emerging targeted therapies for melanoma treatment (review)","volume":"45","author":"Russo","year":"2014","journal-title":"Int. J. Oncol."},{"issue":"1","key":"10.1016\/j.ygeno.2016.04.005_bb0150","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1136\/jcp.2005.034389","article-title":"Chromosome 6p amplification and cancer progression","volume":"60","author":"Santos","year":"2007","journal-title":"J. Clin. Pathol."},{"issue":"4","key":"10.1016\/j.ygeno.2016.04.005_bb0155","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1097\/CMR.0b013e328338a35a","article-title":"Aberrant DNA methylation in malignant melanoma","volume":"20","author":"Schinke","year":"2010","journal-title":"Melanoma Res."},{"issue":"22","key":"10.1016\/j.ygeno.2016.04.005_bb0160","doi-asserted-by":"crossref","first-page":"3206","DOI":"10.1093\/bioinformatics\/btr511","article-title":"survcomp: an R\/Bioconductor package for performance assessment and comparison of survival models","volume":"27","author":"Schroder","year":"2011","journal-title":"Bioinformatics"},{"issue":"1","key":"10.1016\/j.ygeno.2016.04.005_bb0165","doi-asserted-by":"crossref","first-page":"5","DOI":"10.3322\/caac.21254","article-title":"Cancer statistics, 2015","volume":"65","author":"Siegel","year":"2015","journal-title":"CA Cancer J. Clin."},{"issue":"1","key":"10.1016\/j.ygeno.2016.04.005_bb0170","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1038\/jid.2009.177","article-title":"Understanding melanoma signaling networks as the basis for molecular targeted therapy","volume":"130","author":"Smalley","year":"2010","journal-title":"J. Investig. Dermatol."},{"issue":"12","key":"10.1016\/j.ygeno.2016.04.005_bb0175","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1038\/onc.2011.345","article-title":"A novel oncogenic role for the miRNA-506\u2013514 cluster in initiating melanocyte transformation and promoting melanoma growth","volume":"31","author":"Streicher","year":"2012","journal-title":"Oncogene"},{"issue":"6","key":"10.1016\/j.ygeno.2016.04.005_bb0185","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1007\/s10585-010-9307-2","article-title":"Gene signature of the metastatic potential of cutaneous melanoma: too much for too little?","volume":"27","author":"Timar","year":"2010","journal-title":"Clin. Exp. Metastasis"},{"issue":"10","key":"10.1016\/j.ygeno.2016.04.005_bb0190","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1002\/sim.4154","article-title":"On the C-statistics for evaluating overall adequacy of risk prediction procedures with censored survival data","volume":"30","author":"Uno","year":"2011","journal-title":"Stat. Med."},{"issue":"2","key":"10.1016\/j.ygeno.2016.04.005_bb0200","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1093\/bioinformatics\/bts655","article-title":"iBAG: integrative Bayesian analysis of high-dimensional multiplatform genomics data","volume":"29","author":"Wang","year":"2013","journal-title":"Bioinformatics"},{"issue":"7","key":"10.1016\/j.ygeno.2016.04.005_bb0205","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1093\/jnci\/djj103","article-title":"Gene expression profiling of primary cutaneous melanoma and clinical outcome","volume":"98","author":"Winnepenninckx","year":"2006","journal-title":"J. Natl. Cancer Inst."},{"issue":"3","key":"10.1016\/j.ygeno.2016.04.005_bb0210","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1093\/biostatistics\/kxp008","article-title":"A penalized matrix decomposition, with applications to sparse principal components and canonical correlation analysis","volume":"10","author":"Witten","year":"2009","journal-title":"Biostatistics"},{"issue":"10","key":"10.1016\/j.ygeno.2016.04.005_bb0215","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1007\/s10552-014-0443-x","article-title":"Association between BRAFV600E and NRASQ61R mutations and clinicopathologic characteristics, risk factors and clinical outcome of primary invasive cutaneous melanoma","volume":"25","author":"Wu","year":"2014","journal-title":"Cancer Causes Control"},{"issue":"2","key":"10.1016\/j.ygeno.2016.04.005_bb0220","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1093\/bib\/bbu003","article-title":"Combining multidimensional genomic measurements for predicting cancer prognosis: observations from TCGA","volume":"16","author":"Zhao","year":"2015","journal-title":"Brief. Bioinform."},{"key":"10.1016\/j.ygeno.2016.04.005_bb0225","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1111\/j.1467-9868.2005.00527.x","article-title":"Regularization and variable selection via the elastic net","volume":"67","author":"Zou","year":"2005","journal-title":"J. R. Stat. Soc. Ser. B"}],"container-title":["Genomics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S088875431630026X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S088875431630026X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,9,19]],"date-time":"2020-09-19T09:42:13Z","timestamp":1600508533000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S088875431630026X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,6]]},"references-count":42,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2016,6]]}},"alternative-id":["S088875431630026X"],"URL":"https:\/\/doi.org\/10.1016\/j.ygeno.2016.04.005","relation":{},"ISSN":["0888-7543"],"issn-type":[{"value":"0888-7543","type":"print"}],"subject":[],"published":{"date-parts":[[2016,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Integrated analysis of multidimensional omics data on cutaneous melanoma prognosis","name":"articletitle","label":"Article Title"},{"value":"Genomics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ygeno.2016.04.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Inc.","name":"copyright","label":"Copyright"}]}}